Trident Lifeline Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,662,000 (48%) | — | ₹1,679 Cr |
| Retail | — | 1,662,000 (48%) | — | ₹1,679 Cr |
| Market Maker | — | 175,200 (5%) | — | ₹18 Cr |
| Σ Total | — | 3,499,200 (100%) | — | ₹35,342 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹121,200 |
| Retail (Max) | 13 | 15,600 | ₹1,575,600 |
| S-HNI (Min) | 14 | 16,800 | ₹1,696,800 |
| B-HNI (Min) | 67 | 80,400 | ₹8,120,400 |
Financial Statements Amount in Lakhs
| Metric | 31-Mar-20 | 31-Mar-21 | 31-Mar-22 |
|---|---|---|---|
| Revenue | 501 | 978 | 2,237 |
| Profit After Tax | -80 | 63 | 227 |
| Net Worth | -300 | -47 | 480 |
| Total Assets | 639 | 1,144 | 1,386 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 To Meet Working Capital Requirements – 20.50
- 2 Product registration in the International Markets – 5.14
- 3 General Corporate Purpose – 6.71
- 4 Public Issue Expenses – 3.00
Company Overview
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.
Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela.